Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Chimeric antigen receptor T-ce...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management

Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management

Bibliographic Details
Main Authors: Arushi Khurana, Allison C. Rosenthal, Razan Mohty, Mamatha Gaddam, Radhika Bansal, Matthew A. Hathcock, Adrienne N. Nedved, Urshila Durani, Madiha Iqbal, Yucai Wang, Jonas Paludo, J. C. Villasboas, David Dingli, Taxiarchis Kourelis, Nelson Leung, Hassan Alkhateeb, Michael W. Ruff, Alice Gallo de Moraes, Paschalis Vergidis, Joerg Herrmann, Saad S. Kenderian, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin
Format: Article
Language:English
Published: Nature Publishing Group 2024-08-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-024-01119-2
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1038/s41408-024-01119-2

Similar Items

  • Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma
    by: Aldo A. Acosta-Medina, et al.
    Published: (2023-01-01)
  • The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel
    by: Kitsada Wudhikarn, et al.
    Published: (2021-07-01)
  • Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas
    by: Luis F. Porrata, et al.
    Published: (2024-08-01)
  • Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients
    by: Marissa Z. Powell, et al.
    Published: (2023-04-01)
  • Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
    by: Hassan B. Alkhateeb, et al.
    Published: (2022-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs